Literature DB >> 2769394

Brain kininogen following experimental brain injury: evidence for a secondary event.

E F Ellis1, J Chao, M L Heizer.   

Abstract

Previous studies have shown that following experimental brain injury cerebral arterioles dilate and display endothelial lesions and reduced responsiveness to hypocapnia. These abnormalities are caused by cyclo-oxygenase-dependent free radical generation. There is evidence that the kallikrein-kinin system may in part stimulate the cyclooxygenase-dependent damage since bradykinin is a powerful stimulator of prostaglandin formation and it has recently been shown that a specific kinin receptor blocker decreases the arteriolar abnormalities caused by injury. In order to further examine the hypothesis that the kallikrein-kinin system is important in inducing damage, rat brain tissue was examined for kininogen, the precursor of kinins, at 10 minutes and 1, 3, 6, 15, 24, 48, and 72 hours after injury. A fluid-percussion brain injury device was attached over the right cerebral cortex of rats and a 1.6-atmosphere pressure injury was administered. The kininogen content was determined by a radioimmunoassay procedure in tissues which were free of intravascular blood. After injury, bleeding was confined mainly to the right hemisphere. The kininogen content in the right hemisphere was significantly elevated by one hour after injury, continued to rise until 15 hours after injury, then was significantly decreased by 2 days after injury. In the left hemisphere, kininogen was significantly elevated at 1 hour postinjury, returned toward control levels over the 3- to 6-hour period after injury, then was again elevated at 15 hours after injury. These studies also show that brain water and cerebrovascular permeability were greater at 15 hours postinjury than at earlier time points. The data further support a role for the kallikrein-kinin system in brain injury and, when considered with the results of other studies, suggest that a secondary event is occurring in the 12- to 24-hour period after neural injury. The authors hypothesize that this secondary event is related to endothelial and vascular repair and may be important for the return of normal cerebrovascular function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2769394     DOI: 10.3171/jns.1989.71.3.0437

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

1.  The role of bradykinin in the etiology of vasogenic brain edema and perilesional brain dysfunction.

Authors:  I R Whittle; I R Piper; J D Miller
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

2.  Regulation of bradykinin-induced activation of volume-sensitive outwardly rectifying anion channels by Ca2+ nanodomains in mouse astrocytes.

Authors:  Tenpei Akita; Yasunobu Okada
Journal:  J Physiol       Date:  2011-06-20       Impact factor: 5.182

3.  Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment.

Authors:  Hussein Abou-Abbass; Hisham Bahmad; Hadi Abou-El-Hassan; Rui Zhu; Shiyue Zhou; Xue Dong; Eva Hamade; Khalil Mallah; Abir Zebian; Naify Ramadan; Stefania Mondello; Jawad Fares; Youssef Comair; Samir Atweh; Hala Darwish; Kazem Zibara; Yehia Mechref; Firas Kobeissy
Journal:  Electrophoresis       Date:  2016-03-29       Impact factor: 3.535

4.  Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation.

Authors:  Friederike Langhauser; Eva Göb; Peter Kraft; Christian Geis; Joachim Schmitt; Marc Brede; Kerstin Göbel; Xavier Helluy; Mirko Pham; Martin Bendszus; Peter Jakob; Guido Stoll; Sven G Meuth; Bernhard Nieswandt; Keith R McCrae; Christoph Kleinschnitz
Journal:  Blood       Date:  2012-08-30       Impact factor: 22.113

Review 5.  Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.

Authors:  Amaly Nokkari; Hadi Abou-El-Hassan; Yehia Mechref; Stefania Mondello; Mark S Kindy; Ayad A Jaffa; Firas Kobeissy
Journal:  Prog Neurobiol       Date:  2018-01-31       Impact factor: 11.685

6.  Cyclooxygenase-1 and -2 in brains of patients who died with sporadic Creutzfeldt-Jakob disease.

Authors:  Martin H Deininger; Kubrom Bekure-Nemariam; Katrin Trautmann; Matthias Morgalla; Richard Meyermann; Hermann J Schluesener
Journal:  J Mol Neurosci       Date:  2003-02       Impact factor: 3.444

7.  Moderate hypothermia reduces blood-brain barrier disruption following traumatic brain injury in the rat.

Authors:  J Y Jiang; B G Lyeth; M Z Kapasi; L W Jenkins; J T Povlishock
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  The kallikrein-kinin system in the rat hypothalamus. Immunohistochemical localization of high molecular weight kininogen and T kininogen in different neuronal systems.

Authors:  J P Richoux; J L Gelly; J Bouhnik; T Baussant; F Alhenc-Gelas; G Grignon; P Corvol
Journal:  Histochemistry       Date:  1991

9.  LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia.

Authors:  Li Ding-Zhou; Isabelle Margaill; Bruno Palmier; Didier Pruneau; Michel Plotkine; Catherine Marchand-Verrecchia
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

10.  BK Induces cPLA2 Expression via an Autocrine Loop Involving COX-2-Derived PGE2 in Rat Brain Astrocytes.

Authors:  Chih-Chung Lin; Hsi-Lung Hsieh; Shiau-Wen Liu; Hui-Ching Tseng; Li-Der Hsiao; Chuen-Mao Yang
Journal:  Mol Neurobiol       Date:  2014-06-12       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.